• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

‘Steroid phobia’ is leading to treatment failure

International report - Current labeling on topical steroids advising patients to apply sparingly or thinly is causing a ‘steroid phobia’ leading to treatment failure, according to a study.

International report

- Current labeling on topical steroids advising patients to apply sparingly or thinly is causing a ‘steroid phobia’ leading to treatment failure, according to a study published in the

British Journal of Dermatology

.

A group of UK dermatologists say the majority of patients with skin conditions are treated with mild corticosteroids for which there is little risk of adverse effects or skin atrophy. However, they say patients are given a negative, dangerous impression of topical steroids based on advice that should be saved for more potent agents.

The dermatologists found the ‘phobia’ was causing suboptimal treatment of eczema and psoriasis, and suggest labels be changed.

Related Videos
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
© 2024 MJH Life Sciences

All rights reserved.